Skip Navigation


European Heart Journal Advance Access originally published online on April 1, 2009
European Heart Journal 2009 30(9):1151; doi:10.1093/eurheartj/ehp095
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
30/9/1151    most recent
ehp095v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Atar, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atar, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

Hotline sessions of the 30th European Congress of Cardiology

Dan Atar

Division of Cardiology
Aker University Hospital and Faculty of Medicine
University of Oslo
Norway
Tel: +47 23 033 125
Fax: +47 22 894 721
Email: dan.atar@online.no

The first 10% of the full text of this article appears below.

I read with interest the summary of the hotline sessions of this year's ESC Congress provided by Bergman et al.1 The paper discusses the results of the F.I.R.E. study, which investigated the effect of a new drug, FX06 (fibrin-derived peptide Bβ15-42), for the prevention of ischaemia/reperfusion injury in the setting of acute STEMI, which we presented at hotline III. We think that the conclusion given in the . . . [Full Text of this Article]

Funding


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?